Apretude 600 MG per 3 ML Injection

RxCUI: 2588080
RxNorm name: Apretude 600 MG per 3 ML Injection
Display name: Apretude 600 MG per 3 ML Injection
Full name: Apretude 600 MG per 3 ML Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Apretude	CABOTEGRAVIR	ViiV Healthcare Company	4338428e-43d4-4e02-ac9d-bd98e738a7da	2025-04-11	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2588080

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
4338428e-43d4-4e02-ac9d-bd98e738a7da	Apretude 600 MG in 3 ML Extended Release Injection [PSN] · 3 ML cabotegravir 200 MG/ML Injection [Apretude] [SBD] · Apretude 200 MG/ML per 3 ML Injection [SY] · Apretude 600 MG per 3 ML Injection [SY]	4	8	These highlights do not include all the information needed to use APRETUDE safely and effectively. See full prescribing information for APRETUDE. APRETUDE (cabotegravir extended-release injectable suspension), for intramuscular use Initial U.S. Approval: 2021	20250411